ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

Program Announcements

August 3, 2001

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

NCI, NEI Announce Interest In Grants On Ocular, Melanoma

November 21, 1980

2006 demonstration project to pay $23 per office visit.

November 4, 2005

NCI Cooperative Group Clinical Trials Approved

October 29, 2010

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003